{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:43:13Z","timestamp":1766580193799,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Worldwide the rate of unplanned pregnancies is more than 40%. Identifying women at risk of pregnancy can help prevent negative outcomes and also reduce healthcare costs of potential complications. It can also allow the investigation of the natural history of pregnancy outcomes, such as ectopic pregnancies or miscarriages. The use of medical records databases has been a crucial development in the field of pharmacoepidemiology \u2013 e.g. The Health Improvement Network (THIN) database is a validated database representative of the UK population. This project aimed to test the feasibility of identifying a population of women of childbearing age who are at risk of pregnancy not using any contraception in THIN database.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>First a cohort of women of childbearing age (15-45yo) was identified. By applying a computer-based algorithm, containing codes for contraception methods or other suggestion of contraception, the risk of pregnancy was then ascertained. Next, two validation steps were implemented: 1) Revision of medical records\/free text and 2) Questionnaires were sent to primary care practitioners (PCP) of women whose medical records had been reviewed. Positive predicted values (PPV) were calculated.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 266,433 women were identified in THIN. For the first validation step, 123 records were reviewed, with a PPV of 99.2% (95%CI: 95.5\u201399.9). For the questionnaires step, the PPV was of 82.3% (95%CI: 70\u201391.1). Information on sexual behaviour and attitudes towards conception was not captured by THIN.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This study shows that by applying a comprehensive computer-based algorithm, THIN can be used to identify women at risk of pregnancy.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12911-020-01184-0","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T08:03:26Z","timestamp":1595059406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Feasibility study to identify women of childbearing age at risk of pregnancy not using any contraception in The Health Improvement Network (THIN) database"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-0730","authenticated-orcid":false,"given":"Luc\u00eda","family":"Cea Soriano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Asiimwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieke","family":"Van Hemelrijck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Garc\u00eda Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,18]]},"reference":[{"issue":"4","key":"1184_CR1","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1016\/S2214-109X(18)30029-9","volume":"6","author":"J Bearak","year":"2018","unstructured":"Bearak J, Popinchalk A, Alkema L, Sedgh G. Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model. Lancet Glob Health. 2018;6(4):e380\u2013e9.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"1184_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pds.1335","volume":"16","author":"JD Lewis","year":"2007","unstructured":"Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16(4):393\u2013401.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1184_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/jamia.2009.002477","volume":"17","author":"SJ Reisinger","year":"2010","unstructured":"Reisinger SJ, Ryan PB, O'Hara DJ, Powell GE, Painter JL, Pattishall EN, et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc. 2010;17(6):652\u201362.","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"1184_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40264-017-0589-z","volume":"41","author":"Y Yang","year":"2018","unstructured":"Yang Y, Zhou X, Gao S, Lin H, Xie Y, Feng Y, et al. Evaluation of electronic healthcare databases for post-marketing drug safety surveillance and Pharmacoepidemiology in China. Drug Saf. 2018;41(1):125\u201337.","journal-title":"Drug Saf"},{"issue":"9","key":"1184_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/pds.1308","volume":"15","author":"S Hernandez-Diaz","year":"2006","unstructured":"Hernandez-Diaz S. Prescription of medications during pregnancy: accidents, compromises, and uncertainties. Pharmacoepidemiol Drug Saf. 2006;15(9):613\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1184_CR6","unstructured":"FirstDataBank. FDB Multilex 2018 [cited 2019 05\/12\/2019]. Available from: https:\/\/www.fdbhealth.co.uk\/solutions\/multilex."},{"key":"1184_CR7","first-page":"75","volume":"1","author":"CD Stuart-Buttle","year":"1996","unstructured":"Stuart-Buttle CD, Read JD, Sanderson HF, Sutton YM. A language of health in action: read codes, classifications and groupings. Proc AMIA Annu Fall Symp. 1996;1:75\u20139.","journal-title":"Proc AMIA Annu Fall Symp"},{"key":"1184_CR8","volume-title":"Preconception care: maximizing the gains for maternal and child health","author":"WHO","year":"2013","unstructured":"WHO. Preconception care: maximizing the gains for maternal and child health. Geneva: World Health Organization; 2013."},{"key":"1184_CR9","volume-title":"Immune modulating therapies in pregnancy and lactation: American College of Obstetricians and Gynecologists","author":"ACOG","year":"2019","unstructured":"ACOG. Immune modulating therapies in pregnancy and lactation: American College of Obstetricians and Gynecologists; 2019. [Cited 2019 01\/12\/2019]. Available from: https:\/\/www.acog.org\/Clinical-Guidance-and-Publications\/Committee-Opinions\/Committee-on-Obstetric-Practice\/Immune-Modulating-Therapies-in-Pregnancy-and-Lactation?IsMobileSet=false."},{"issue":"1","key":"1184_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12884-019-2400-x","volume":"19","author":"AP Londero","year":"2019","unstructured":"Londero AP, Rossetti E, Pittini C, Cagnacci A, Driul L. Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study. BMC Pregnancy Childbirth. 2019;19(1):261.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1184_CR11","first-page":"2015","volume-title":"Public costs from unintended pregnancies and the role of public insurance programs in paying for pregnancy-related care. National and state estimates for 2010","author":"A Sonfield","year":"2015","unstructured":"Sonfield A, Kost K. Public costs from unintended pregnancies and the role of public insurance programs in paying for pregnancy-related care. National and state estimates for 2010; 2015. p. 2015."},{"issue":"1","key":"1184_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/13625187.2013.852170","volume":"19","author":"L Cea Soriano","year":"2014","unstructured":"Cea Soriano L, Wallander MA, Andersson SW, Requena G, Garcia-Rodriguez LA. Study of long-acting reversible contraceptive use in a UK primary care database: validation of methodology. Eur J Contracept Reprod Health Care. 2014;19(1):22\u20138.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"1184_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/13625187.2014.948613","volume":"19","author":"L Cea Soriano","year":"2014","unstructured":"Cea Soriano L, Wallander M-A, Andersson S, Filonenko A, Garc\u00eda Rodr\u00edguez LA. Use of long-acting reversible contraceptives in the UK from 2004 to 2010: analysis using the health improvement network database. Eur J Contracept Reprod Health Care. 2014;19(6):439\u201347.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"1184_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/pds.3877","volume":"25","author":"L Cea Soriano","year":"2016","unstructured":"Cea Soriano L, Soriano-Gabarro M, Garcia Rodriguez LA. Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom. Pharmacoepidemiol Drug Saf. 2016;25(4):385\u201391.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1184_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/pds.3926","volume":"25","author":"L Cea Soriano","year":"2016","unstructured":"Cea Soriano L, Soriano-Gabarro M, Garcia Rodriguez LA. Validation of low-dose aspirin prescription data in the health improvement network: how much misclassification due to over-the-counter use? Pharmacoepidemiol Drug Saf. 2016;25(4):392\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1184_CR16","first-page":"251","volume":"19","author":"BT Blak","year":"2011","unstructured":"Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19(4):251\u20135.","journal-title":"Inform Prim Care"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-01184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-020-01184-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-01184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T23:15:21Z","timestamp":1626563721000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-020-01184-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,18]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1186\/s12911-020-01184-0","relation":{},"ISSN":["1472-6947"],"issn-type":[{"type":"electronic","value":"1472-6947"}],"subject":[],"published":{"date-parts":[[2020,7,18]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by an independent scientific review committee for THIN (reference number 14-080R). <b>Consent for publication:<\/b> Non-applied.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}